MED Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03
Price $11.73
Market Cap (MRQ) $131M
P/E (TTM) -5.1
EPS (TTM) $-2.32
Revenue (TTM) $317M
Div Yield 0.15%
ROE (TTM) -12.4%
52W Range $9–$14

MED Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04
range
bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

About MEDIFAST INC Common Stock Company overview from Wikipedia

05 · wikidata

Medifast, Inc. (NYSE: MED) is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

Subsidiaries

The company owns five subsidiaries:

Jason Pharmaceuticals, Inc.

Take Shape for Life, Inc. (TSFL) (renamed Optavia from July 2017)

Jason Enterprises, Inc.

Jason Properties, LLC

Seven Crondall, LLC

History

William Vitale, a medical doctor, founded Medifast in 1980. He sold his products directly to other doctors, who in turn prescribed them to their patients alongside behavioural counselling techniques.

The company is publicly traded on the New York Stock Exchange (symbol: MED).

On July 17, 1995, HealthRite (predecessor of Medifast) changed its name from Vitamin Specialties Corp.

In 2000 the company pivoted to a direct-to-consumer marketing program with the help of Jason Pharmaceuticals and in 2001, the company changed its name to Medifast, Inc. In 2002, Retired Marine Colonel Bradley T. MacDonald, Chairman of the Board at the time, along with clinical specialist Dr. Wayne Scott Andersen, created Take Shape For Life as a personal Coach to the Client system and the company's “Habits of Health System.”

In October 2010, Medifast was ranked number 1 on Forbes magazine's list of "America's 100 Best Small Companies". The company was ranked 18th on the 2014 list.

Medifast was named one of Forbes's 100 Most Trustworthy Companies in America in 2016 and 2017.

In July 2017, Medifast changed the name of its subsidiary Take Shape For Life to Optavia and introduced a new line of products, Optavia Essentials, directly sold from Coaches to clients.

In October 2017, Medifast relocated its headquarters to Baltimore from Owings Mills, Maryland. The company is public with a market capitalization of $2.106 billion, as of June 2022.

In December 2023, Medifast announced a partnership with LifeMD, a provider of virtual healthcare services. Under the agreement, Medifast will use LifeMD's virtual platform to offer Medifast clients a clinically supported weight management program, including the option for prescription GLP-1 medications where clinically appropriate. In return, LifeMD will provide its patients with an independent Medifast Coach and additional lifestyle support services for weight management.

False advertising settlement

In September 2012, Medifast's subsidiary, Jason Pharmaceuticals, paid a $3.7 million USD civil penalty for false advertising. The Federal Trade Commission and United States Department of Justice said that advertisements for the "Medifast 5 & 1 Plan" low-calorie diet told consumers they could "lose up to 2-5 pounds per week", and that these weight-loss claims lacked a reasonable scientific basis, and were unsubstantiated. Under the settlement, any future claims made by the company must be backed by at least one human clinical study.

Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗

Wikidata ↗

sectorConsumer products industryConsumer products employees380 countryUS

10-Year Performance Revenue, net income, margins and EPS trends

06
Revenue$386M
2016-12-31 → 2025-12-31
EPS$-1.70
2016-12-31 → 2025-12-31
Free Cash Flow$1M
2016-12-31 → 2025-12-31
Net margin-8.1%
2016-12-31 → 2025-12-31
Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric 5Y trend MED 5Y avg Peer Median Verdict
P/E (TTM) -5.15Y avg ≈23.6 ≈23.6 · ·
P/S (TTM) 0.45Y avg ≈0.7 ≈0.7 0.8 Undervalued
P/B (MRQ) 0.75Y avg ≈5.0 ≈5.0 2.2 Undervalued
Price / FCF (TTM) 32.75Y avg ≈31.6 ≈31.6 · ·
Price / Cash Flow (TTM) 14.95Y avg ≈12.4 ≈12.4 13.9 Pricier
Price / Tangible Book 0.65Y avg ≈5.0 ≈5.0 · ·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

value · ≈ 5Y avg · industry median · verdict relative to median

Dividends Yield, payout ratio, dividend history, 5Y CAGR

13
Dividend Yield0.15%
Payout Ratio-1.0%
Annualized Payout≈$6.60Paid quarterly
Ex-dateAmountCurrencyYield
Sep 18, 2023$1.65USD≈8.2%
Jun 26, 2023$1.65USD≈7.3%
Mar 27, 2023$1.65USD≈6.6%
Dec 19, 2022$1.64USD≈5.7%
Sep 19, 2022$1.64USD≈5.4%
Jun 27, 2022$1.64USD≈3.2%
Mar 28, 2022$1.64USD≈3.5%
Dec 20, 2021$1.42USD≈2.6%
Sep 20, 2021$1.42USD≈2.5%
Jun 21, 2021$1.42USD≈1.9%
Mar 29, 2021$1.42USD≈2.3%
Dec 21, 2020$1.13USD≈2.3%
Sep 21, 2020$1.13USD≈3.1%
Jun 29, 2020$1.13USD≈3.0%
Mar 30, 2020$1.13USD≈5.9%
Dec 26, 2019$1.13USD≈3.1%
Sep 26, 2019$0.75USD≈3.0%
Jun 27, 2019$0.75USD≈2.5%
Mar 28, 2019$0.75USD≈1.9%
Dec 20, 2018$0.75USD≈1.8%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14
Avg Surprise 54.6%
Next Report Nov 02, 2026
PeriodReportEPS ActualEPS EstSurprise
June 30, 2026 Aug 10, 2026 $-0.28 $-0.66 57.3%
March 31, 2026 $-0.19 $-0.53 63.8%
Dec. 31, 2025 $-1.65 $-0.83 -99.2%
Sept. 30, 2025 $-0.21 $-0.39 46.7%
June 30, 2025 $0.22 $-0.22 199.0%
March 31, 2025 $-0.11 $-0.27 59.7%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15
Income Statement 15
Metric Trend 202520242023202220212020201920182017201620152014
Revenue $386M$602M$1.07B$1.60B$1.53B$935M$714M$501M$302M$275M$273M$285M
Cost of Revenue $111M$158M$296M$458M$398M$237M$177M$121M$74M$69M$71M$76M
Gross Profit $275M$445M$776M$1.14B$1.13B$698M$537M$380M$228M$206M$201M$209M
R&D Expense $4M$5M$5M$4M$4M$3M$3M$2M$2M$2M$2M$1M
SG&A Expense $289M$442M$649M$956M$911M$564M$446M$311M$188M$179M$173M$179M
Operating Income $-14M$3M$126M$185M$216M$134M$91M$69M$40M$27M$29M$30M
Other Non-op $3M$-4M$-95.0K$-747.0K$119.0K$-140.0K$29.0K$179.0K$136.0K$-20.0K$326.0K$731.0K
Pretax Income $-6M$4M$129M$184M$216M$134M$92M$71M$40M$27M$30M$32M
Income Tax $13M$2M$29M$40M$52M$31M$14M$15M$13M$9M$10M$11M
Net Income $-19M$2M$99M$144M$164M$103M$78M$56M$28M$18M$20M$13M
EPS (Basic) $-1.70$0.19$9.13$12.82$14.01$8.74$6.62$4.67$2.32$1.51$1.68$1.04
EPS (Diluted) $-1.70$0.19$9.10$12.73$13.89$8.68$6.43$4.62$2.29$1.49$1.66$1.03
Shares (Basic) 10,981,00010,930,00010,884,00011,195,00011,705,00011,771,00011,771,00011,947,00011,924,00011,842,00011,959,00012,670,000
Shares (Diluted) 10,981,00010,963,00010,921,00011,276,00011,813,00011,850,00012,117,00012,079,00012,088,00011,947,00012,071,00012,778,000
EBITDA $29.0K$16M$140M$196M$223M$141M$96M$73M$44M$32M$36M·
Balance Sheet 24
Metric Trend 202520242023202220212020201920182017201620152014
Cash & Equivalents $89M$91M$94M$88M$104M$164M$77M$81M$75M$52M$42M$24M
Short-term Investments $78M$71M$56M$0$5M$11M$16M$20M$24M$24M$25M$28M
Receivables ·····$584.0K$1M$1M$576.0K$1M$2M$2M
Inventory $20M$42M$55M$119M$180M$53M$49M$39M$19M$18M$13M$16M
Prepaid Expense $9M$10M$11M$16M$16M$6M$6M$5M$4M$4M$3M$3M
Current Assets $202M$214M$224M$223M$307M$234M$154M$146M$125M$101M$87M$82M
PP&E (Net) $31M$38M$51M$57M$56M$28M$26M$20M$19M$20M$29M$33M
PP&E (Gross) $99M$96M$99M$97M$89M$55M$49M$54M$52M$56M$75M$74M
Accum. Depreciation $68M$58M$47M$40M$33M$27M$23M$35M$33M$36M$46M$40M
Other Non-current Assets $8M$10M$15M$12M$6M$3M$353.0K$1M$2M$162.0K$205.0K$497.0K
Total Assets $248M$284M$310M$316M$398M$276M$195M$169M$146M$121M$116M$116M
Accounts Payable $38M$56M$86M$135M$163M$108M$76M$60M$37M$24M$23M$22M
Current Liabilities $43M$64M$92M$141M$170M$111M$79M$60M$37M$24M$24M$27M
Capital Leases $6M$10M$16M$20M$26M$7M$10M···$0$242.0K
Deferred Tax ········$208.0K$779.0K$4M$5M
Total Liabilities $49M$74M$108M$161M$196M$119M$90M$60M$37M$25M$28M$35M
Common Stock $11.0K$11.0K$11.0K$11.0K$12.0K$12.0K$12.0K$12.0K$12.0K$12.0K$12.0K$12.0K
Paid-in Capital $40M$33M$27M$22M$12M$8M·$9M$5M$3M$0$1M
Retained Earnings $158M$177M$175M$140M$190M$154M$169M$131M$104M$93M$89M$79M
Treasury Stock ··$0$6M$0$5M$64M$31M···$0
AOCI $234.0K$180.0K$248.0K$24.0K$111.0K$41.0K$25.0K$-173.0K$-160.0K$-165.0K$-62.0K$435.0K
Stockholders' Equity $199M$210M$201M$155M$202M$157M$105M$109M$107M$96M$89M$80M
Liabilities + Equity $248M$284M$310M$316M$398M$276M$195M$169M$146M$121M$116M$116M
Shares Outstanding 10,991,00010,938,00010,896,00010,873,00011,593,00011,772,00011,764,00011,868,00011,971,00011,871,00011,797,00012,075,764
Cash Flow 16
Metric Trend 202520242023202220212020201920182017201620152014
D&A $14M$13M$13M$11M$7M$4M$5M$4M$4M$5M$7M$8M
Stock-based Comp $8M$7M$8M$11M$10M$7M$5M$3M$4M$3M$3M$4M
Deferred Tax $11M$-7M$1M$-924.0K$-4M$601.0K$2M$-3M$-623.0K$-3M$-106.0K$286.0K
Restructuring ·········$1M··
Other Non-cash $-8M$10M$26M$30M$-82M$28M$-4M$155.0K$8M$2M$-737.0K·
Operating Cash Flow $7M$24M$148M$195M$95M$145M$84M$61M$43M$25M$29M$26M
CapEx $6M$7M$6M$17M$34M$6M$10M$5M$3M$3M$3M$7M
Investing Cash Flow $-8M$-27M$-61M$-11M$-29M$-1M$-6M$-1M$-3M$-2M$-189.0K$-3M
Net Debt Issued ·········$-219.0K$-255.0K·
Stock Repurchased $0$0$4M$126M$56M$5M$33M$30M··$11M$34M
Net Stock Activity $0$0$-4M$-126M$-56M$-5M$-33M$-30M··$-11M·
Dividends Paid $195.0K$715.0K$73M$72M$64M$53M$35M$23M$15M$12M··
Financing Cash Flow $-564.0K$-2M$-80M$-200M$-125M$-57M$-82M$-53M$-17M$-13M$-12M$-35M
Net Change in Cash $-2M$-4M$7M$-16M$-60M$87M$-4M$6M$23M$10M$18M$-12M
Taxes Paid $10M$-2M$34M$37M········
Free Cash Flow $1M$17M$141M$178M$60M$139M$74M$56M$40M$22M$27M·
Profitability 8
Metric Trend 202520242023202220212020201920182017201620152014
Gross Margin 71.3%73.8%72.4%71.3%73.9%74.7%75.2%75.8%75.5%74.9%73.8%·
Operating Margin -3.7%0.48%11.8%11.6%14.2%14.3%12.8%13.8%13.1%9.8%10.5%·
Net Margin -4.8%0.35%9.3%9.0%10.8%11.0%10.9%11.1%9.2%6.5%7.3%·
Pretax Margin -1.5%0.63%12.0%11.5%14.2%14.4%12.9%14.1%13.4%9.9%10.9%·
EBITDA Margin 0.01%2.6%13.0%12.2%14.6%15.1%13.4%14.7%14.5%11.8%13.1%·
ROA -7.0%0.70%31.8%40.2%48.6%43.7%42.8%35.4%20.8%15.0%17.2%·
ROE -9.0%1.0%50.4%94.0%82.3%69.2%72.1%50.5%27.1%19.3%23.7%·
ROIC -23.7%0.76%48.4%93.0%81.1%65.4%73.3%50.1%25.1%18.4%21.3%·
Liquidity & Solvency 2
Metric Trend 202520242023202220212020201920182017201620152014
Current Ratio 4.73.32.41.61.82.11.92.43.44.13.7·
Quick Ratio 3.92.51.00.60.61.61.21.72.73.22.9·
Efficiency 3
Metric Trend 202520242023202220212020201920182017201620152014
Asset Turnover 1.42.03.44.54.54.03.93.22.32.32.3·
Inventory Turnover 3.53.33.43.13.44.64.04.13.94.44.9·
Receivables Turnover ·····925.1583.1467.4307.2181.8166.2·
Per Share 6
Metric Trend 202520242023202220212020201920182017201620152014
Book Value / Share $18.10$19.21$18.49$14.26$17.47$13.36$8.91$9.19$9.07$8.09$7.51·
Revenue / Share $35.13$54.95$98.16$141.77$129.19$78.89$58.90$41.48$24.95$22.98$22.60·
Cash Flow / Share $0.62$2.23$13.52$17.26$8.00$12.25$6.95$5.03$3.58$2.12$2.44·
Cash / Share $8.13$8.31$8.67$8.06$8.99$13.91$6.54$6.86$6.27$4.42$3.56·
Dividend / Share $0.00$0.00$4.95$6.56$5.68$4.52$3.38$2.19$1.44$1.07$0.25$0.00
EPS (TTM) $-1.70$0.19$9.10$12.73$13.89$8.68$6.43$4.62$2.29$1.49$1.66$1.03
Growth Rates 8
Metric Trend 202520242023202220212020201920182017201620152014
Revenue YoY -36.0%-43.8%-32.9%4.8%63.2%·······
Revenue CAGR 3Y -37.7%-26.6%4.7%·········
Revenue CAGR 5Y -16.2%···········
EPS YoY ·-97.9%-28.5%-8.3%60.0%·······
EPS CAGR 3Y ·-76.1%1.6%·········
Net Income YoY ·-97.9%-30.8%-12.5%59.5%·······
Net Income CAGR 3Y ·-76.6%-1.1%·········
Dividends Paid CAGR 5Y -67.4%···········
Valuation (TTM) 13
Metric Trend 202520242023202220212020201920182017201620152014
Revenue TTM $386M$602M$1.07B$1.60B$1.53B$935M$714M$501M$302M$275M$273M$285M
Net Income TTM $-19M$2M$99M$144M$164M$103M$78M$56M$28M$18M$20M$13M
Market Cap $117M$193M$732M$1.25B$2.43B$2.31B$1.29B$1.48B$836M$494M$358M·
P/E -6.392.77.49.115.122.617.027.130.527.918.332.6
P/S 0.30.30.70.81.62.51.83.02.81.81.3·
P/B 0.60.93.68.112.014.712.313.67.75.14.0·
P / Tangible Book 0.60.93.68.112.014.7······
P / Cash Flow 17.17.95.06.425.715.915.324.419.319.512.2·
P / FCF 94.011.35.27.140.216.617.426.620.922.013.5·
Dividend Yield 0.17%0.37%10.0%5.7%2.6%2.3%2.8%1.6%1.8%2.4%··
Earnings Yield -15.9%1.1%13.5%11.0%6.6%4.4%5.9%3.7%3.3%3.6%5.5%3.1%
Payout Ratio -1.0%34.2%73.5%49.9%38.9%51.7%45.4%41.5%55.5%66.7%··
Annual Payout $195.0K$715.0K$73M$72M$64M$53M$35M$23M$15M$12M··

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16
Metric 2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue $386M $602M $1.07B $1.60B $1.53B
Gross Margin % 71.3% 73.8% 72.4% 71.3% 73.9%
Operating Margin % -3.7% 0.48% 11.8% 11.6% 14.2%
Net Income $-19M $2M $99M $144M $164M
Diluted EPS $-1.70 $0.19 $9.10 $12.73 $13.89

Institutional owners (13F) 123 filers · $106.7M total · As of June 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 123
Value held $106.7M
New positions 26
Exited positions 24
Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
26 (-5 vs prior Q) 24 (+7 vs prior Q) 47 (+12 vs prior Q) 29 (-4 vs prior Q) -931K

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
RENAISSANCE TECHNOLOGIES LLC $8,261,052 778,610 7.74% Shares
VANGUARD GROUP INC $7,598,810 711,499 7.12% Shares
Steamboat Capital Partners, LLC $7,498,076 706,699 7.03% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $5,758,047 542,700 5.40% Call option
TWO SIGMA INVESTMENTS, LP $5,107,452 481,381 4.79% Shares
VANGUARD CAPITAL MANAGEMENT LLC $4,738,575 446,614 4.44% Shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $4,212,128 396,996 3.95% Shares
BlackRock, Inc. $3,920,427 369,503 3.68% Shares
DIMENSIONAL FUND ADVISORS LP $3,855,669 363,394 3.61% Shares
AMERICAN CENTURY COMPANIES INC $3,383,646 318,911 3.17% Shares
MORGAN STANLEY $3,103,524 292,508 2.91% Shares
GOLDMAN SACHS GROUP INC $2,579,132 243,085 2.42% Shares
MARSHALL WACE, LLP $2,563,897 241,649 2.40% Shares
AQR CAPITAL MANAGEMENT LLC $2,508,564 236,434 2.35% Shares
CITADEL ADVISORS LLC $2,476,374 233,400 2.32% Call option
Peapod Lane Capital LLC $2,361,531 222,576 2.21% Shares
Lido Advisors, LLC $2,337,779 220,337 2.19% Shares
Trexquant Investment LP $2,256,577 212,684 2.12% Shares
JANE STREET GROUP, LLC $1,749,388 164,881 1.64% Shares
COMMONS CAPITAL, LLC $1,590,609 149,916 1.49% Shares
Quinn Opportunity Partners LLC $1,348,658 127,112 1.26% Shares
GEODE CAPITAL MANAGEMENT, LLC $1,285,312 121,071 1.20% Shares
BRIDGEWAY CAPITAL MANAGEMENT, LLC $1,242,198 117,078 1.16% Shares
RBF Capital, LLC $1,156,490 109,000 1.08% Shares
Walleye Trading LLC $1,145,880 108,000 1.07% Call option
TWO SIGMA ADVISERS, LP $1,098,972 102,900 1.03% Shares
JPMORGAN CHASE & CO $989,878 92,512 0.93% Shares
D. E. Shaw & Co., Inc. $979,780 92,345 0.92% Shares
BANK OF AMERICA CORP /DE/ $924,323 87,118 0.87% Shares
Quantinno Capital Management LP $880,598 82,997 0.83% Shares
Divisadero Street Capital Management, LP $847,092 79,839 0.79% Shares
Virtus Family Office LLC $838,827 79,060 0.79% Shares
TUDOR INVESTMENT CORP ET AL $806,689 76,031 0.76% Shares
BNP PARIBAS FINANCIAL MARKETS $783,846 73,878 0.73% Shares
FEDERATED HERMES, INC. $738,509 69,605 0.69% Shares
Empowered Funds, LLC $701,374 66,105 0.66% Shares
CITADEL ADVISORS LLC $696,016 65,600 0.65% Put option
VANGUARD FIDUCIARY TRUST CO $672,006 63,337 0.63% Shares
Atom Investors LP $659,083 62,119 0.62% Shares
CITADEL ADVISORS LLC $597,873 56,350 0.56% Shares
STATE STREET CORP $555,105 52,319 0.52% Shares
GREAT LAKES ADVISORS, LLC $547,593 51,611 0.51% Shares
UBS Group AG $532,866 50,223 0.50% Shares
Engineers Gate Manager LP $528,686 49,829 0.50% Shares
MILLENNIUM MANAGEMENT LLC $508,283 47,906 0.48% Shares
SummerHaven Investment Management, LLC $507,529 47,835 0.48% Shares
Centiva Capital, LP $471,424 44,432 0.44% Shares
Susquehanna Portfolio Strategies, LLC $443,254 41,777 0.42% Shares
Jump Financial, LLC $429,705 40,500 0.40% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $422,278 39,800 0.40% Put option

Show all 123 institutional owners →

Activists & 5%+ owners 8 positions

18

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
Parsa Kiai, Steamboat Capital Partners, LLC Aug. 21, 2026 7.10% Amendment · SEC
Steamboat Capital Partners, LLC, Parsa Kiai March 20, 2026 6.00% Initial filing Board campaign SEC
Engaged Capital Flagship Master Fund, LP, Engaged Capital Co-Invest X, LP, Engaged Capital Co-Invest X-A, LP, Engaged Capital Opportunities Fund, LP, Engaged Capital Flagship Fund, LP, Engaged Capital Flagship Fund, Ltd., Engaged Capital, LLC, Engaged Capital Holdings, LLC, Glenn W. Welling ×5 filings July 15, 2020 · Initial filing · SEC
Engaged Capital Master Feeder II, LP, Engaged Capital Master Feeder I, LP, Engaged Capital I, LP, Engaged Capital I Offshore, Ltd., Engaged Capital II, LP, Engaged Capital II Offshore Ltd., Engaged Capital, LLC, Engaged Capital Holdings, LLC, Glenn W. Welling June 3, 2016 · Initial filing · SEC
ModusLink Securities Corp., ModusLink Global Solutions, Inc. ×6 filings Jan. 19, 2016 · Initial filing · SEC
Engaged Capital Master Feeder I, LP, Engaged Capital Master Feeder II, LP, Engaged Capital I, LP, Engaged Capital I Offshore, Ltd., Engaged Capital II, LP, Engaged Capital II Offshore Ltd., Engaged Capital, LLC, Engaged Capital Holdings, LLC, Glenn W. Welling ×4 filings Sept. 1, 2015 · Initial filing · SEC
Undisclosed reporting person, Undisclosed reporting person Dec. 12, 2002 · Initial filing · SEC
Undisclosed reporting person, Undisclosed reporting person May 6, 2002 · Initial filing Passive investment SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Company insiders 52 insiders · 20 officers · 28 directors

19
Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Michael S Mcdevitt Chief Executive Officer Jan. 5, 2011 S 340,012 0 0 $0
James P. Maloney Chief Financial Officer March 25, 2026 A 73,033 0 0 $0
Timothy G Robinson Chief Financial Officer Feb. 20, 2020 F 47,214 0 0 $0
Connors Brendan Chief Financial Officer Jan. 5, 2011 S 91,484 0 0 $0
Mehrnaz Mona Ameli President, OPTAVIA Nov. 17, 2017 F 10,809 0 0 $0
Margaret Macdonald Sheetz President & COO April 1, 2016 S 327,346 0 0 $0
Jonathan Barrett Mackenzie VP, Finance & CAO March 25, 2026 A 20,838 0 0 $0
Stephen Kyle Johnson VP, Finance & CAO March 17, 2021 A 665 0 0 $0
Joseph P Kelleman Vice President of Finance Feb. 20, 2019 A 2,355 0 0 $0
Jason L Groves Executive VP & General Counsel Feb. 17, 2015 A 21,697 0 0 $0
Jeanette M. Mills Executive Vice President Aug. 18, 2014 S 20,116 0 0 $0
Guy Sheetz Executive Vice President Feb. 5, 2014 A 410,430 0 0 $0
Dominick Vietri Executive Vice President Feb. 5, 2014 A 3,804 0 0 $0
Brian Lloyd Executive Vice President Feb. 5, 2014 A 1,865 0 0 $0
Donald Gould Executive Vice President Feb. 5, 2014 A 6,804 0 0 $0
Brian Kagen Executive Vice President Feb. 5, 2014 A 3,804 0 0 $0
Jeanne M Uphouse Executive Vice President Feb. 5, 2014 A 3,804 0 0 $0
Brazdley T Macdonald Exec. Chairman of the Board Jan. 5, 2011 S 579,521 0 0 $0
Leo Williams Executive Vice President Nov. 29, 2010 S 15,000 0 0 $0
Robert J Hallock Corporate Vice President Nov. 18, 2003 P 1,000 0 0 $0
Daniel R Chard Director Sept. 29, 2026 S 130,609 1 2 $-47,575
Parsa Kiai Director Aug. 26, 2026 P 20,270 8 0 $1,423,577
Jeffrey Matthew Rose Director May 26, 2026 A 18,419 0 0 $0
Elizabeth A. Geary Director May 26, 2026 A 31,225 0 0 $0
Andrea B Thomas Director May 26, 2026 A 35,697 0 0 $0
Ming Xian Director May 26, 2026 A · 0 0 $0
Scott Schlackman Director May 26, 2026 A 42,229 2 0 $62,950
Michael A. Hoer Director June 25, 2025 A 26,139 0 0 $0
Jeffrey J Brown Director June 25, 2025 A 38,578 0 0 $0
Kevin G Byrnes Director Nov. 11, 2021 M 14,922 0 0 $0
Michael C Macdonald Director Oct. 1, 2020 S 266,179 0 0 $0
Carl E Sassano Director July 17, 2020 G 18,199 0 0 $0
Charles P Connolly Director March 9, 2018 M 41,374 0 0 $0
Welling Glenn W. Director Dec. 1, 2017 S 22,380 0 0 $0
Jorgene K. Hartwig Director March 13, 2017 M 9,808 0 0 $0
Barry B Bondroff Director June 11, 2015 S 14,533 0 0 $0
John P Mcdaniel Director June 4, 2015 S 18,289 0 0 $0
Jerry D Reece Director Feb. 17, 2015 A 8,792 0 0 $0
Harvey C Barnum JR Director Feb. 17, 2015 A 8,742 0 0 $0
Catherine T Maguire Director Feb. 17, 2015 A 15,074 0 0 $0
Donald F Reilly Director Feb. 17, 2015 A 0 0 0 $0
George Lavin Director July 31, 2013 D 24,785 0 0 $0
Joseph D Calderone Director March 24, 2009 A 21,700 0 0 $0
Carthy Dennis Mc Director March 24, 2009 A 17,075 0 0 $0
Michael J Mcdevitt Director Feb. 15, 2007 A 17,400 0 0 $0
VISIUM BALANCED MASTER FUND, LTD. 10% owner May 31, 2016 S 0 0 0 $0
Constance J. Hallquist · Oct. 6, 2023 S 2,152 0 0 $0
Shirley Macdonald · May 12, 2010 S 0 0 0 $0
Mary T Travis · Dec. 17, 2009 S 12,583 0 0 $0
Richard J Law · Aug. 13, 2009 S 62,081 0 0 $0
RNI-NV Limited Partnership · Aug. 8, 2005 S 1,088,830 0 0 $0
Scott Zion · July 28, 2004 P 185,000 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 18 ETFs

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
VRIG · Invesco Actively Managed Exchange-T… 0.27% 5,000,000 Sept. 30, 2026 Daily
IWC · iShares Trust 0.03% 36,261 SH Sept. 11, 2026 Daily
VSS · VANGUARD INTERNATIONAL EQUITY INDEX… 0.01% 16,856 SH Aug. 19, 2026 Daily
DFSV · Dimensional ETF Trust 0.01% 60,623 NS July 31, 2026 N-PORT
DXUV · Dimensional ETF Trust 0.00% 2,012 NS July 31, 2026 N-PORT
DFAS · Dimensional ETF Trust 0.00% 37,570 NS July 31, 2026 N-PORT
PRFZ · Invesco Exchange-Traded Fund Trust 0.00% 5,427 SH Sept. 30, 2026 Daily
DCOR · Dimensional ETF Trust 0.00% 2,019 NS July 31, 2026 N-PORT
DFUS · Dimensional ETF Trust 0.00% 2,079 NS July 31, 2026 N-PORT
DFAC · Dimensional ETF Trust 0.00% 5,600 NS July 31, 2026 N-PORT
VXF · VANGUARD INDEX FUNDS 0.00% 115,543 SH Aug. 19, 2026 Daily
VTI · VANGUARD INDEX FUNDS 0.00% 318,980 SH Aug. 19, 2026 Daily
VXUS · VANGUARD STAR FUNDS 0.00% 64,351 SH Aug. 19, 2026 Daily
VGK · VANGUARD INTERNATIONAL EQUITY INDEX… 0.00% 9,806 SH Aug. 19, 2026 Daily
VT · VANGUARD INTERNATIONAL EQUITY INDEX… 0.00% 3,076 SH Aug. 19, 2026 Daily
VEA · VANGUARD TAX-MANAGED FUNDS 0.00% 42,929 SH Aug. 19, 2026 Daily
VSGX · VANGUARD WORLD FUND 0.00% 1,003 SH Aug. 19, 2026 Daily
SMLF · iShares Trust · 123,005 SH Sept. 11, 2026 Daily

MED Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21
rating · 9 analysts SELL
Median target $12.00 +2.3%
0 0.0% Strong Buy
0 0.0% Buy
4 44.4% Hold
4 44.4% Sell
1 11.1% Strong Sell

12-Month Price Target

1 analysts · 2026-09-27

Mean target $12.00 +2.3%

Low$12.00 Mean$12.00 High$12.00

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
MED $117M -6.3 -36.0% -4.8% -9.0% 71.3%
USNA $355M 33.5 8.3% 1.2% 2.0% 78.3%
NUS · 3.0 -14.3% 10.8% 22.0% 69.5%
NATR $378M 20.4 5.7% 4.1% 12.0% 72.4%
NAGE $507M 31.8 29.9% 13.4% 24.7% 64.3%
UPXI $62M -0.2 58.1% -984.3% 9654.9% 89.5%
FTLF · 25.8 26.4% · · ·
SKIN $177M -8.7 -10.0% -3.2% -14.1% 65.3%
LFVN $78M 15.6 -20.1% 2.8% 15.2% 77.6%

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Source: SEC 10-Q filed Aug 3, 2026